Gemcitabine inhibits cisplatin resistance in cisplatin-resistant A549 cells by upregulating trx-interacting protein and inducing cell cycle arrest
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 524 (3) , 549-554
Abstract
No abstract availableKeywords
Funding Information
- Hunan Provincial Natural Science Foundation
- National Natural Science Foundation of China
This publication has 22 references indexed in Scilit:
- Cisplatin resistance and opportunities for precision medicinePharmacological Research, 2016
- D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 ExpressionThe Tohoku Journal of Experimental Medicine, 2016
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung CancerPLOS ONE, 2013
- MondoA Senses Non-glucose SugarsJournal of Biological Chemistry, 2011
- Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancerCritical Reviews in Oncology/Hematology, 2011
- Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancerGenes & Development, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysisJNCI: Journal of the National Cancer Institute, 2007
- Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinomaHead & Neck, 2005
- Cross Resistance and Collateral Sensitivity Studies in Cancer Chemotherapy1963